Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Acucort, Alnylam, Alvotech, Amneal, Amolyt, Anheart, Antengene, Aquestive, Ascletis, Astellas, Atara, Aytu, Biocardia, Cabaletta, Celyad, CTI, Design, Fera, Finch, Gilead, Harpoon, Hutchmed, Innocare, Innovent, Janssen, Karyopharm, Kempharm, Legend, Mydecine, Nicox, Pfizer, Radius, Redcloud, Regenerx, Statera, Urogen, Valneva, Zynerba.